Related Experiment Videos
[Immuno-hemolytic transfusion reactions. IV. Analysis, risks and prevention]
A M Tissier1, P Y Le Pennec, E Hergon
1Centre National de Référence pour les Groupes Sanguins, INTS, Paris, France.
Summary
The immunological risk of red blood cell transfusions outweighs viral risks. Improving clinical procedures and implementing quality assurance systems are key to enhancing transfusion safety.
Area of Science:
- Immunology
- Transfusion Medicine
- Patient Safety
Context:
- The immunological risk associated with red blood cell transfusions is a significant concern, potentially exceeding viral risks.
- Severe hemolytic transfusion reactions due to blood incompatibility occur with notable frequency, despite advancements in technology.
- Most transfusion accidents stem from errors in clinical procedures rather than laboratory or production issues.
Purpose:
- To highlight the shift in transfusion risk from viral to immunological factors.
- To emphasize the critical role of clinical procedures in transfusion safety.
- To outline preventive strategies and the importance of quality assurance systems.
Summary:
- Immunological risks now dominate red blood cell transfusion safety concerns, surpassing viral threats.
- Blood incompatibility reactions occur frequently (1/6000 to 1/29000), often due to clinical procedural defects.
- Prevention relies on clinical guidelines, strict bedside ABO checks, antibody screening, and robust quality assurance systems.
Impact:
- Enhanced transfusion safety is expected through the implementation of quality assurance and epidemiological surveillance.
- Focusing on clinical procedural improvements can significantly reduce transfusion-related accidents.
- A proactive approach to transfusion safety is crucial for patient well-being.